Norsk Hydro
24.6.2026 08:00:00 CEST | Globenewswire | Press release
Norsk Hydro: Invitation to Hydro's second quarter results 2026
Norsk Hydro: Invitation to Hydro's second quarter results 2026
Hydro's second quarter results 2026 will be released at 07:00 CEST (01:00 EDT, 06:00 BST, 05:00 UTC/GMT) on July 22, 2026. The quarterly report and presentation will be available on hydro.com at the same time as the release.
President and CEO Eivind Kallevik, and Executive Vice President and CFO Trond Olaf Christophersen, will host a webinar in English at 08:30 CEST the same day. A Q&A session will follow directly after the presentation. There will be no physical presentation or press conference.
To join the webinar and ask questions, please use the link to the webcast page.
The webcast is powered by Zoom. No login or advance registration is required.
It is also possible to join the conference using the dial-in option:
Norway +47 2400 4736
London, UK +44 330 088 5830
New York, US +1 929 205 6099
Meeting ID: 935 7810 1684
We advise you to check in advance whether your company has any restrictions on using the Zoom platform.
Investor contact:
Baard Erik Haugen
+47 92497191
erik.haugen@hydro.com
Valentina Gandolfi
+47 95882355
Valentina.gandolfi@hydro.com
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
CGTN20.9.2026 11:26:23 CEST | Pressemeddelelse
CGTN:CGTN-undersøgelse | Hvorfor får SCO’s løsning på global styring stor opmærksomhed?
Chery Auto20.9.2026 06:23:11 CEST | Press release
LEPAS Expands Global Presence with Progress Across Multiple Markets
Sunwin20.9.2026 05:13:15 CEST | Press release
MG Commercial Makes IAA Transportation 2026 Debut with Two All-Electric Buses
CGTN19.9.2026 08:41:28 CEST | Press release
CGTN:CGTN Poll | Why is the SCO Solution for Global Governance Drawing Wide Attention?
Teva Pharmaceutical Industries Ltd18.9.2026 22:32:00 CEST | Press release
New Teva Study Identifies the Attributes that Healthcare Providers Prioritize when Selecting a Treatment for Tardive Dyskinesia in Older Patients
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom